|
|
Volumn 13, Issue 5, 2002, Pages 505-509
|
|
Phase I study of carboplatin, irinotecan and docetaxel on a divided schedule with recombinant human granulocyte colony stimulating factor support in patients with stage IIIB or IV non-small cell lung cancer
a
|
|
Author keywords
Diarrhea; Docetaxel; Irinotecan; Non small cell lung cancer; Phase I study
|
|
Indexed keywords
CARBOPLATIN;
DEXAMETHASONE;
DOCETAXEL;
IRINOTECAN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
GRANULOCYTE COLONY STIMULATING FACTOR;
PACLITAXEL;
RECOMBINANT PROTEIN;
TAXOID;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BACTERIAL OVERGROWTH;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CYTOTOXICITY;
DIARRHEA;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
INTESTINE MUCOSA;
LUNG NON SMALL CELL CANCER;
MALE;
MAXIMUM TOLERATED DOSE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADENOCARCINOMA;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
FOLLOW UP;
INTRAVENOUS DRUG ADMINISTRATION;
LARGE CELL CARCINOMA;
LUNG TUMOR;
MIDDLE AGED;
PATHOLOGY;
SQUAMOUS CELL CARCINOMA;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARBOPLATIN;
CARCINOMA, LARGE CELL;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
DIARRHEA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FOLLOW-UP STUDIES;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMAN;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGE;
PACLITAXEL;
RECOMBINANT PROTEINS;
HUMANS;
MIDDLE AGED;
TAXOIDS;
|
|
EID: 0035987083
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-200206000-00009 Document Type: Article |
|
Times cited : (7)
|
|
References (13)
|
